Emily

[Emily @EmilyVerbus]

Congrats on an amazing tea talk @TKhan_GS! Your work is both impressive and compelling and I've been lucky to see its evolution over the past two years.

[NCI Surgical Oncology Research Fellows @NCI_SurgOncFel]

Congratulations @TKhan_GS on the culmination of 3 years of excellent work in the lab of @JMHernandez_MD #surgeonscientist #cholangiocarcinoma #HPB

[Emily @EmilyVerbus]

Congrats @stephielux_ ! I have loved working with you on this project. Your hard work, dedication, and intelligence never cease to amaze me!

[Emily @EmilyVerbus]

@Shahyan_Rehman @rwjsurgery @JMHernandez_MD @YaleSurgRes Congrats Shy!!! You are going to be an amazing surgeon!

[Emily @EmilyVerbus]

@shirleynah @aarit_ahuja Ugh why could I not find these??

[Emily @EmilyVerbus]

We're starting our skin cancer clinical trial spotlight looking at different treatment regimens for #melanoma previously treated with #immunotherapy. Check it out! @AnnSurgOncol @JMHernandez_MD

[National Cancer Institute @theNCI]

Should response to #immunotherapy before surgery dictate the selection of immunotherapy after surgery for patients with #melanoma? https://t.co/PWuqfXH8fN
@AnnSurgOncol @NCICCR_SurgOnc #CancerResearch

[Emily @EmilyVerbus]

Check out our final breast cancer trial examining new strategies to slow the progression of DCIS! @AnnSurgOncol @JMHernandez_MD

[National Cancer Institute @theNCI]

Can treatment with a drug called bazedoxifene slow the progression of ER-positive #DCIS? https://t.co/snLvWwmhly
@AnnSurgOncol @NCICCR_SurgOnc @NCIResearchCtr #CancerResearch

[Emily @EmilyVerbus]

Happy National Women Physicians Day! Lucky to work with these fierce female surgeons at the @NCI_SurgOncFel.
@TekeMartha @ReebaSaif @CarrieRyanMD @sarvestani_md @stephgregory_md @shirleynah @LaurenGambleMD

[NCI Surgical Oncology Research Fellows @NCI_SurgOncFel]

Celebrating our amazing fellows @NCI_SurgOncFel ! From us to you - Happy National Women’s Physicians Day #womeninsurgery#ilooklikeasurgeon#womenempoweringwomen#IamBlackwell

[Vanessa Ho, MD, PhD, MPH (she/her) @vanessapho]

Students thinking about #GeneralSurgery... consider Metrohealth in Cleveland

@MHGenSurgery @metrohealthCLE
@Sigfre_10 @pkanuika_md @AFeriaMD
@ImAJHaas @TheresaRelation @EmilyVerbus

https://t.co/xxuC0TEbVd

[Emily @EmilyVerbus]

@JMHernandez_MD explains why we believe highlighting ongoing clinical trials in surgical oncology in our new series is such an important endeavor. Check it out! @AnnSurgOncol

[Society of Surgical Oncology @SocSurgOnc]

On Speaking of SurgOnc from @AnnSurgOncol, Rick Greene, MD & Jonathan M. Hernandez, MD, discuss the need for surgical oncologists to keep informed of ongoing research & the launch of a editorial series to address challenges in meeting this need. Listen at https://t.co/ICbZIZRRoN.

[Emily @EmilyVerbus]

Our next trial examines the effect of radiation combined with immunotherapy for the treatment of #breastcancer. Check it out! @JMHernandez_MD @AnnSurgOncol

[National Cancer Institute @theNCI]

Can radiation therapy make #breastcancer more responsive to #immunotherapy treatment? https://t.co/05EvJoXbHc @AnnSurgOncol @tchou_julia @NCICCR_SurgOnc #CancerResearch

[Emily @EmilyVerbus]

Our next clinical trial spotlight is investigating whether ALND is necessary for node-positive breast cancer treated with radiation therapy. Check it out! @JMHernandez_MD @AnnSurgOncol

[National Cancer Institute @theNCI]

Is axillary radiation therapy without axillary lymph node dissection sufficient for the treatment of sentinel node-positive #BreastCancer? https://t.co/3E4Q0j897U @AnnSurgOncol @DrJudyBoughey @NCICCR_SurgOnc #CancerResearch #bcsm

[Emily @EmilyVerbus]

Check out our first breast cancer clinical trial spotlight looking at neoadjuvant radiation for #DCIS. @JMHernandez_MD @AnnSurgOncol

[National Cancer Institute @theNCI]

Does neoadjuvant #radiotherapy improve outcomes in ductal carcinoma in situ? https://t.co/V1hzgqfZio @AnnSurgOncol @wapnir @NCICCR_SurgOnc #CancerResearch #DCIS

[Emily @EmilyVerbus]

Our last hepatobiliary clinical trial spotlight is out! It looks into how best to bridge to transplant for #HCC. @JMHernandez_MD @AnnSurgOncol

[National Cancer Institute @theNCI]

Can we increase the number of #LiverTransplants for patients with hepatocellular carcinoma with radiation or chemoembolization? https://t.co/scQXQsLf7T @AnnSurgOncol @NCICCR_SurgOnc #CancerResearch

[Emily @EmilyVerbus]

Check out the next trial in our series and learn about new strategies to improve outcomes of #hepatocellularcarcinoma treated with #immunotherapy. @AnnSurgOncol @JMHernandez_MD

[National Cancer Institute @theNCI]

Can we improve the results of #immunotherapy for patients with #hepatocellularcarcinoma with the addition of CCR2/5 or IL-8 inhibitors? Find out more: https://t.co/SLb9ZCcJT6 @TischCancer @AnnSurgOncol @NCICCR_SurgOnc #CancerResearch

[Emily @EmilyVerbus]

Check out the second trial spotlighted this month focusing on #gallbladdercancer! @AnnSurgOncol @JMHernandez_MD

[National Cancer Institute @theNCI]

Can the addition of neoadjuvant chemotherapy improve survival in patients with #GallbladderCancer? https://t.co/SbWqk4ye9r @WinshipAtEmory @AnnSurgOncol @NCICCR_SurgOnc #CancerResearch

[Emily @EmilyVerbus]

@Hanna__Hong was an awesome labmate last year! I know she'll do great things in med school and beyond!

[Emily @EmilyVerbus]

Check out our first #hepatobiliary clinical trial spotlight looking into hepatic artery infusion pump treatment for unresectable #cholangiocarcinoma. @AnnSurgOncol @JMHernandez_MD

[National Cancer Institute @theNCI]

Should hepatic artery infusion pump therapy be the initial treatment for some patients with #cholangiocarcinoma? https://t.co/xK9yYgvAdA @AndreaCercek @sloan_kettering @AnnSurgOncol @NCICCR_SurgOnc #CancerResearch

[Emily @EmilyVerbus]

The last of the #colorectal trials is out! Starting next week: #hepatobiliary. @AnnSurgOncol @JMHernandez_MD

[National Cancer Institute @theNCI]

Can the #ColorectalCancer tumor microenvironment be altered with a combination of immunotherapy and drugs that target SEMA4D? https://t.co/1OUipVjWDG @AnnSurgOncol @NCICCR_SurgOnc @WuGiOnc @LesinskiLab #CancerResearch #TME

[Emily @EmilyVerbus]

Third installment is out! Find out more about the ICARuS trial looking at EPIC vs #HIPEC. https://t.co/GnFfrjPQK7 @JMHernandez_MD @AnnSurgOncol

[National Cancer Institute @theNCI]

Should #AppendixCancer that spreads in the abdomen be treated with intraperitoneal #chemotherapy DURING or just AFTER surgery? https://t.co/fFwn2fpD7d @AnnSurgOncol @NCISurgOnc #CancerResearch #icarustrial

[Emily @EmilyVerbus]

Our second featured study is out! Check out the LUNA Trial examining metastatic #coloncancer to the liver and lungs. @JMHernandez_MD @AnnSurgOncol

[National Cancer Institute @theNCI]

A new clinical trial is testing liver surgery and #chemotherapy for treating #ColorectalCancer that has spread to the liver and the lungs. https://t.co/ag6PVF4mi2 @AnnSurgOncol @MDAndersonNews @NCICCR_SurgOnc #CancerResearch